3-(2-(3-(4-bromophenyl)-4-oxo-3,4-dihydroquinazolin-2-yl)hydrazinecarbothioamido)benzoic acid

ID: ALA4294388

Chembl Id: CHEMBL4294388

PubChem CID: 145993882

Max Phase: Preclinical

Molecular Formula: C22H16BrN5O3S

Molecular Weight: 510.37

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(O)c1cccc(NC(=S)NNc2nc3ccccc3c(=O)n2-c2ccc(Br)cc2)c1

Standard InChI:  InChI=1S/C22H16BrN5O3S/c23-14-8-10-16(11-9-14)28-19(29)17-6-1-2-7-18(17)25-21(28)26-27-22(32)24-15-5-3-4-13(12-15)20(30)31/h1-12H,(H,25,26)(H,30,31)(H2,24,27,32)

Standard InChI Key:  BZQYVTUHBYKYDP-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA4294388

    ---

Associated Targets(Human)

MIA PaCa-2 (5949 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Cckbr Cholecystokinin B receptor (729 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Cckbr Cholecystokinin B receptor (792 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 510.37Molecular Weight (Monoisotopic): 509.0157AlogP: 4.16#Rotatable Bonds: 5
Polar Surface Area: 108.28Molecular Species: ACIDHBA: 6HBD: 4
#RO5 Violations: 1HBA (Lipinski): 8HBD (Lipinski): 4#RO5 Violations (Lipinski): 1
CX Acidic pKa: 3.93CX Basic pKa: 2.35CX LogP: 4.94CX LogD: 1.88
Aromatic Rings: 4Heavy Atoms: 32QED Weighted: 0.23Np Likeness Score: -1.57

References

1. Kumari S, Chowdhury J, Sikka M, Verma P, Jha P, Mishra AK, Saluja D, Chopra M..  (2017)  Identification of potent cholecystokinin-B receptor antagonists: synthesis, molecular modeling and anti-cancer activity against pancreatic cancer cells.,  (7): [PMID:30108868] [10.1039/C7MD00171A]

Source